Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/91984
PIRA download icon_1.1View/Download Full Text
Title: Development of antiviral CVC (Chief Value Cotton) fabric
Authors: Wang, WY 
Yim, SL
Wong, CH
Kan, CW 
Issue Date: Aug-2021
Source: Polymers, Aug. 2021, v. 13, no. 16, 2601
Abstract: The outbreak of COVID-19 has already generated a huge societal, economic and political losses worldwide. The present study aims to investigate the antiviral activity of Poly(hexamethylene biguanide) hydrochloride (PHMB) treated fabric against COVID-19 by using the surrogate Feline coronavirus. The antiviral analysis indicated that up to 94% of coronavirus was killed after contacting the CVC fabric treated with PHMB for 2 h, which suggests that PHMB treated fabric could be used for developing protective clothing and beddings with antiviral activity against coronavirus and can play a role in fighting the transmission of COVID-19 in the high-risk places.
Keywords: Antibacterial agent
Coronavirus
CVC fabric
PHMB
Protective clothing
Publisher: Molecular Diversity Preservation International (MDPI)
Journal: Polymers 
ISSN: 2073-4360
DOI: 10.3390/polym13162601
Rights: © 2021 by the authors.Licensee MDPI, Basel, Switzerland.This article is an open access articledistributed under the terms andconditions of the Creative CommonsAttribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
The following publication Wang, W.-Y.; Yim, S.-L.;Wong, C.-H.; Kan, C.-W. Developmentof Antiviral CVC (Chief Value Cotton)Fabric. Polymers 2021, 13, 2601 is available at https://doi.org/10.3390/polym13162601
Appears in Collections:Journal/Magazine Article

Files in This Item:
File Description SizeFormat 
polymers-13-02601.pdf1.26 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show full item record

Page views

1
Citations as of May 15, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.